Ask HopeStage to review this study with me
Study ID: NCT03593213. We help you review the study, but cannot decide medical eligibility.
TerminatedNCT03593213
Safety study of cariprazine in schizophrenia
This study was terminated in the United States, in Bulgaria, in Malaysia, .... It is testing cariprazine for schizophrenia.
SchizophreniaDrugFrom 18 Years to 64 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
Bulgaria · 10 sites
- Mental Health Centre - Prof.Dr.Ivan Temkov-BurgasBurgasSite status: Not listed — confirm with the team
- State Psychiatry HospitalKardzhaliSite status: Not listed — confirm with the team
- MHAT Dr. Hristo Stambolski" EOOD; Department of PsychiatryKazanlakSite status: Not listed — confirm with the team
- State Psyciiatric Hospital - LovechLovechSite status: Not listed — confirm with the team
- UMHAT Dr. Georgi Stranski, EADPlevenSite status: Not listed — confirm with the team
- Mental health Centre-Ruse EOODRousseSite status: Not listed — confirm with the team
- MHAT-Targovishte, ADTargovishteSite status: Not listed — confirm with the team
- DCC Mladost M - Varna, OODVarnaSite status: Not listed — confirm with the team
- Mental Health Center - Veliko Tarnovo EOOD, Veliko TarnovoVeliko TarnovoSite status: Not listed — confirm with the team
- Mental Health Center - Vratsa EOOD, VratsaVratsaSite status: Not listed — confirm with the team
Malaysia · 3 sites
- University Kuala LumpurIpohSite status: Not listed — confirm with the team
- University Malaya Medical CenterKuala LumpurSite status: Not listed — confirm with the team
- Hospital SentosaKuchingSite status: Not listed — confirm with the team
Poland · 5 sites
- Szpital Uniwersytecki Nr.1 im. Dr. A. Jurasza, Klinika PsychiatriiBydgoszczSite status: Not listed — confirm with the team
- Samodzielny Publiczny Zespół Opieki ZdrowotnejChełmnoSite status: Not listed — confirm with the team
- Centrum Badan Klinicznych PI-HouseGdanskSite status: Not listed — confirm with the team
- Specjalistyczna Praktyka lekarskaLublinSite status: Not listed — confirm with the team
- Indywidualna Specjalistyczna PraktykaPoznanSite status: Not listed — confirm with the team
Puerto Rico · 1 site
- INSPIRA Clinical ResearchSan JuanSite status: Not listed — confirm with the team
Romania · 5 sites
- Spitalul de Psihiatrie si Neurologie BrasovBrasovSite status: Not listed — confirm with the team
- Spitalul de Psihiatrie TITAN "Dr. Constantin Gorgoș", Bulevardul Nicolae Grigorescu, Nr. 41BucharestSite status: Not listed — confirm with the team
- Armys Clinical Emergency Central Hospital Prof Dr Carol DavilaBucharestSite status: Not listed — confirm with the team
- CETTT SF Stelian HospitalBucharestSite status: Not listed — confirm with the team
- Spital Clinic Judetean Tg. MuresTârgu MureşSite status: Not listed — confirm with the team
Serbia · 8 sites
- Clinical Center of SerbiaBelgradeSite status: Not listed — confirm with the team
- Clinical Hospital Center Dr. Dragisa Misovic-DedinjeBelgradeSite status: Not listed — confirm with the team
- Institute of Mental HealthBelgradeSite status: Not listed — confirm with the team
- Special Hospital for Psychiatric Diseases "Kovin"KovinSite status: Not listed — confirm with the team
- Clinical Centre KragujevacKragujevacSite status: Not listed — confirm with the team
- Clinical Centre KragujevacKragujevacSite status: Not listed — confirm with the team
- Specialized Hospital for Neuropsychiatric Diseases Sveti VraceviNovi KneževacSite status: Not listed — confirm with the team
- Clinic for Psychiatry, Clinical Centre of VojvodinaNovi SadSite status: Not listed — confirm with the team
South Korea · 5 sites
- Inje University Busan Paik HospitalBusanSite status: Not listed — confirm with the team
- Inje University Heaundae Paik HospitalBusanSite status: Not listed — confirm with the team
- Chonnam National University HospitalGwangjuSite status: Not listed — confirm with the team
- Gachon University Gil Medical CenterIncheonSite status: Not listed — confirm with the team
- Jeju National University HospitalJeju CitySite status: Not listed — confirm with the team
Taiwan · 3 sites
- Taipei Tzu Chi HospitalNew Taipei CitySite status: Not listed — confirm with the team
- National Cheng Kung University HospitalTainanSite status: Not listed — confirm with the team
- Department of Psychiatry, Taipei Veterans General Hospital, TaiwanTaipeiSite status: Not listed — confirm with the team
Thailand · 1 site
- Suan prung Psychiatric HospitalNonthaburiSite status: Not listed — confirm with the team
Ukraine · 14 sites
- Regional Psychonevrological Hospital #3Ivano-FrankivskSite status: Not listed — confirm with the team
- Kharkiv regional clinical psychiatric hospital #3KharkivSite status: Not listed — confirm with the team
- Institute of Neurology, Psychiatry and Narcology of the NAMS of UkraineKharkivSite status: Not listed — confirm with the team
- SI Institute of Neurology, Psychiatry and Narcology of NAMSUKharkivSite status: Not listed — confirm with the team
- Kyiv Railway Clinical Hospital #2 of Branch "Health Center" of the Public Joint Stock Company "Ukrainian Railway"vKyivSite status: Not listed — confirm with the team
- Kyiv Regional Medical Incorporation "Psychiatry"KyivSite status: Not listed — confirm with the team
- Geikivka multidisciplinary hospital for psychiatric careKyivSite status: Not listed — confirm with the team
- KNP of Lviv Regional Council "Lviv Regional Clinical Psychiatric Hospital"LvivSite status: Not listed — confirm with the team
- Odessa Regional Medical Centre of Mental HealthOdesaSite status: Not listed — confirm with the team
- Odesa Regional Psychiatric Hospital No.2 of the ORCOdesaSite status: Not listed — confirm with the team
- Kherson Regional Psychiatric Institution for Psychiatric CarePetrivkaSite status: Not listed — confirm with the team
- Cherkasy regional psychiatric hospital of the CRCSmilaSite status: Not listed — confirm with the team
- CI O.I. Yuschenko VRPsH Depts No.14 and No.15 M.I. Pyrogov VNMUVinnytsiaSite status: Not listed — confirm with the team
- VNMUVinnytsiaSite status: Not listed — confirm with the team
United States · 42 sites
- Pillar Clinical ResearchBentonville, ArkansasSite status: Not listed — confirm with the team
- Woodland International Research GroupLittle Rock, ArkansasSite status: Not listed — confirm with the team
- Woodland Research Northwest, LLCRogers, ArkansasSite status: Not listed — confirm with the team
- Advanced Research Center, Inc.Anaheim, CaliforniaSite status: Not listed — confirm with the team
- CITrials - BellflowerBellflower, CaliforniaSite status: Not listed — confirm with the team
- Synexus Clinical Research US, Inc.Cerritos, CaliforniaSite status: Not listed — confirm with the team
- ATP Clinical Research, Inc.Costa Mesa, CaliforniaSite status: Not listed — confirm with the team
- California Pharmaceutical Research Institute, Inc.Costa Mesa, CaliforniaSite status: Not listed — confirm with the team
- ProScience Research GroupCulver City, CaliforniaSite status: Not listed — confirm with the team
- Collaborative Neuroscience Research Network, LLC.Garden Grove, CaliforniaSite status: Not listed — confirm with the team
- Behavioral Research Specialists, LLCGlendale, CaliforniaSite status: Not listed — confirm with the team
- Omega Clinical TrialsLa Habra, CaliforniaSite status: Not listed — confirm with the team
- Synergy San DiegoLemon Grove, CaliforniaSite status: Not listed — confirm with the team
- Alliance ResearchLong Beach, CaliforniaSite status: Not listed — confirm with the team
- Excell Research, IncOceanside, CaliforniaSite status: Not listed — confirm with the team
- Orange County Neuropsychiatric Research Center, LLCOrange, CaliforniaSite status: Not listed — confirm with the team
- CNRI-Los AngelesPico Rivera, CaliforniaSite status: Not listed — confirm with the team
- University of California San DiegoSan Diego, CaliforniaSite status: Not listed — confirm with the team
- Schuster Medical Research InstituteSherman Oaks, CaliforniaSite status: Not listed — confirm with the team
- Collaborative Neuroscience Research, LLCTorrance, CaliforniaSite status: Not listed — confirm with the team
- Wilks & Safirstein MD PA D/B/A MD ClinicalHallandale, FloridaSite status: Not listed — confirm with the team
- Southern Winds HospitalHialeah, FloridaSite status: Not listed — confirm with the team
- Research Centers of AmericaHollywood, FloridaSite status: Not listed — confirm with the team
- Synexus Clinical Research, IncAtlanta, GeorgiaSite status: Not listed — confirm with the team
- Atlanta Center for Medical ResearchAtlanta, GeorgiaSite status: Not listed — confirm with the team
- iResearch Atlanta LLCDecatur, GeorgiaSite status: Not listed — confirm with the team
- Atlanta Behavioral Research, LLCDunwoody, GeorgiaSite status: Not listed — confirm with the team
- AMITA Health Alexian Brothers Center for Psychiatric ResearchHoffman Estates, IllinoisSite status: Not listed — confirm with the team
- Louisiana Clinical ResearchShreveport, LouisianaSite status: Not listed — confirm with the team
- CBH Health LLCGaithersburg, MarylandSite status: Not listed — confirm with the team
- Altea ResearchLas Vegas, NevadaSite status: Not listed — confirm with the team
- Alea Research InstituteLas Vegas, NevadaSite status: Not listed — confirm with the team
- Hassman Research InstituteBerlin, New JerseySite status: Not listed — confirm with the team
- Neurobehavioral Research, Inc.Cedarhurst, New YorkSite status: Not listed — confirm with the team
- New Hope Clinical ResearchCharlotte, North CarolinaSite status: Not listed — confirm with the team
- Clinical Inquest Center Ltd.Beavercreek, OhioSite status: Not listed — confirm with the team
- OSY Psychiatry DepartmentColumbus, OhioSite status: Not listed — confirm with the team
- Professional Psychiatric ServicesMason, OhioSite status: Not listed — confirm with the team
- Sooner Clinical ResearchOklahoma City, OklahomaSite status: Not listed — confirm with the team
- Community Clinical Research, Inc.Austin, TexasSite status: Not listed — confirm with the team
- Pillar Clinical ResearchRichardson, TexasSite status: Not listed — confirm with the team
- Pillar HealthcareRichardson, TexasSite status: Not listed — confirm with the team
Key information made simple
What is this study testing?
This study is testing whether Cariprazine may be useful for adults experiencing schizophrenia.
What would participation involve?
Participants may receive Cariprazine, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in Bulgaria, in Malaysia, and in Poland.
Who is it mainly for?
This study appears to be mainly for adults with schizophrenia.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Study sites are listed in the registry. Recruitment status can differ between sites. Ask the research team to confirm the location, any in-person visits, time commitment, costs or compensation, and participation criteria.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
Study start dateStarted: July 30, 2018
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 587
- Sponsor
- AbbVie
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States, Bulgaria, Malaysia, ...
- Age range
- From 18 Years to 64 Years
- Official registry ID
- NCT03593213
- Official title
- A Double-Blind, Placebo-Controlled, Randomized Withdrawal, Multicenter Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Patients With Schizophrenia
- Official source
- Official registry link
Want help reviewing this study?
Study ID: NCT03593213. We help you review the study, but cannot decide medical eligibility.
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving Cariprazine, Placebo. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.
Who might this study be for?
This study may concern people with schizophrenia; age range: From 18 Years to 64 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by AbbVie, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
TerminatedNCT01568216
20101299: Study Effect of AMG 747 on Schizophrenia Negative Symptoms
This study was terminated in the United States, in Australia, in Canada, .... It focuses on schizophrenia.
TerminatedNCT01568229
20110165: Study Effect of AMG 747 on Schizophrenia Negative Symptoms (Study 165)
This study was terminated in the United States, in France, in the United Kingdom, .... It focuses on schizophrenia.
TerminatedNCT00946985
28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years
This study was terminated in the United States, in Canada, in Brazil, .... It focuses on schizophrenia.